Buyer’s Guide
6 Best EDC Software Platforms for Small and Mid-Sized CROs
The best electronic data capture (EDC) platforms for small and mid-sized CROs in 2026 are Clinion, Viedoc, Medrio, Castor, TrialKit, and OpenClinica. Clinion offers AI-enabled clinical data management and connected eClinical workflows, while Viedoc and Medrio emphasize configurable study management. Castor supports patient-centric data collection, TrialKit offers no-code and mobile capabilities, and OpenClinica combines configurable EDC with managed study-build services.
For CROs managing multiple sponsor studies, the right EDC platform should support efficient study setup, protocol amendments, data review, and reporting without excessive technical resources or vendor dependency.
Why Small and Mid-Sized CROs Need a Different Approach to Choosing EDC Software
Three sponsors. Three protocols. Three sets of eCRFs, edit checks, and reporting requirements. Now one of them introduces a protocol amendment while the other two studies are mid-enrollment.
A larger CRO may have dedicated programming resources to handle these changes. At a smaller CRO, the same work can fall on an already stretched data manager or require vendor support, adding time and cost to an active study. And amendments are far from uncommon: a 2024 Tufts CSDD analysis of 950 protocols found that 76% had at least one amendment, up from 57% in an earlier study.
This is where the flexibility of an EDC platform matters. Clinion EDC supports mid-study amendments without system downtime, allowing teams to update visits, forms, and fields while preserving existing data through version control. It also brings AI-assisted data review, natural-language reporting, and connected eClinical workflows into the same environment.
This guide compares Clinion with five other EDC platforms (Viedoc, Medrio, Castor, TrialKit, and OpenClinica) on what matters to small and mid-sized CROs: study configuration, amendment flexibility, AI capabilities, data review and reporting, integrations, multi-sponsor management, and total operating costs.
Quick Comparison of the 6 Best EDC Software Platforms
Clinion
How We Selected These EDC Platforms
We reviewed official product documentation, security disclosures, and independent G2 and Capterra reviews, alongside publicly available information on implementation and support. The comparison prioritizes documented capabilities over marketing claims and notes gaps where information was unavailable or unverified.
Platforms are presented for comparison, not numerical ranking.
Detailed Comparison of the 6 Best EDC Software Platforms for CROs in 2026
Clinion EDC
Best suited for: Small and mid-sized CROs seeking configurable EDC software with AI-assisted clinical data management and connected eClinical workflows.
Clinion EDC combines codeless study configuration with AI-enabled tools for study setup, data review, medical coding, and reporting. Its approach is particularly relevant to CROs managing multiple sponsor studies, where reducing repetitive configuration work and manual data review can help lean teams manage their workload.
Clinion also offers Agentic Assistant, a multi-agent AI assistant integrated within its EDC. It allows clinical teams to retrieve protocol information, explore operational metrics, query live clinical data, and generate reports using natural language.
Key capabilities
- Study configuration: Build eCRFs, define edit checks, configure visit schedules, and reuse standardized forms and study templates through global libraries, all without routine programming
- Protocol amendments: Modify visits, forms, and fields during active studies without system downtime, with version control to preserve existing data.
- AI-assisted study setup: Use AI-assisted CDASH mapping and protocol-driven study development capabilities to reduce repetitive configuration work.
- Clinical data review: Support source data verification, discrepancy detection, medical coding, query management, and AI-assisted data review.
- Agentic Assistant: Ask study-specific questions, retrieve clinical data, generate custom reports, and work with integrated data review capabilities within EDC.
- Connected eClinical workflows: Integrate EDC with Clinion’s RTSM, CTMS, ePRO, eConsent, eSource, eTMF, and other clinical trial applications.
Why it may work for small and mid-sized CROs
Clinion’s value lies in combining configurable EDC with AI-assisted workflows. For a CRO with limited data management resources, this can reduce dependence on specialist programmers for routine study changes and reporting requests.
Agentic Assistant extends these capabilities by bringing protocol intelligence, operational insights, and clinical data querying into a single conversational interface within Clinion EDC. Data managers can retrieve information, create custom reports, review clinical data, and raise queries from relevant records without relying solely on predefined reports or separate data extraction workflows.
This combination of configurable EDC and AI-assisted review is particularly relevant to CROs looking to handle growing study portfolios without proportionally increasing manual data management work.
Considerations
CROs should evaluate the scope of Agentic Assistant included in their license, the availability of particular AI capabilities, support for sponsor-specific access controls, and the effort required for third-party integrations. AI-generated findings and proposed queries should remain subject to appropriate human review.
Pricing: Custom quotation. Publicly disclosed pricing is insufficient to estimate per-study or portfolio costs reliably.
What Clinion EDC Users Say
G2 Rating: 4.6/5 | Read Clinion EDC Reviews on G2
Viedoc EDC
Best for: CROs managing multiple sponsor studies that need reusable configurations and flexible amendment management.
Viedoc EDC offers a low-code study design environment that enables teams to build and maintain studies using reusable forms, edit checks, and configurable workflows. Its ability to run multiple study configuration versions simultaneously is particularly useful for managing protocol amendments without disrupting ongoing data collection.
Key capabilities
- Low-code study design with reusable global libraries and CDASH-aligned templates.
- Concurrent study versions and amendments without downtime.
- Query management, SDV, reporting, and AI-assisted medical coding.
- Portfolio licensing with unlimited users under applicable plans.
Why consider Viedoc? Its reusable design environment and version management can help CROs standardize study builds while accommodating different sponsor requirements.
Considerations: Complex logic may require JavaScript. CROs should verify the availability of advanced AI capabilities and obtain pricing based on their study portfolio.
Pricing: Quote-based, with single-study and portfolio licensing options.
What Users Say About Viedoc
Medrio EDC
Best for: Lean CRO teams prioritizing independent study configuration and straightforward clinical data management.
Medrio EDC focuses on no-code study building, allowing data managers to configure eCRFs, edit checks, and study workflows without routine programming support. Its self-service approach extends to protocol amendments, with testing environments for reviewing changes before deployment.
Key capabilities
- No-code study configuration with reusable templates and edit checks.
- Self-managed amendments and study validation environments.
- Query management, dashboards, reporting, and data exports.
- Integrated ePRO/eCOA, eConsent, RTSM, and other eClinical capabilities.
Why consider Medrio? Its configuration flexibility and CRO Partner Program may suit smaller teams looking to manage routine study changes internally while retaining access to implementation support.
Considerations: Publicly documented native AI capabilities are less extensive than those of some competitors. CROs should assess advanced reporting needs and vendor support arrangements.
Pricing: Custom quotation, with CRO-specific tiered pricing available.
What Users Say About Medrio EDC
Castor EDC
Best for: CROs conducting EHR-intensive, decentralized, or source-data-heavy studies.
Castor EDC combines configurable data capture with patient-facing tools and clinical data management capabilities. Its distinguishing offering is Catalyst, which uses AI to extract relevant information from source documents and EHR data for human review before entry into clinical trial records.
Key capabilities
- Low-code eCRF development and reusable study forms.
- FormSync for controlled amendments without downtime.
- Catalyst AI for source-data extraction and human-verified review.
- FHIR-based EHR connectivity, eCOA/ePRO, and eConsent.
Why consider Castor? Its source-data integration capabilities may be particularly valuable for CROs managing studies that require substantial data collection from medical records or external systems.
Considerations: Catalyst is an additional-cost capability. Certain structural amendments may require renewed verification or review of existing records.
Pricing: Custom quotation based on study scope, modules, and services.
What Users Say About Castor EDC
TrialKit EDC
Best for: CROs seeking no-code study configuration, multi-study control, and AI-assisted study development.
TrialKit, developed by Crucial Data Solutions, combines configurable EDC with a broader set of eClinical tools. Its Floyd AI capabilities extend beyond reporting to study generation, simulation, and validation, making it relevant to teams frequently setting up new studies.
Key capabilities
- No-code study design with reusable forms, workflows, and edit checks.
- Self-managed amendments and multi-study administration.
- Floyd AI for study generation, simulation, validation, and data analysis.
- Integrated eSource, ePRO, eConsent, RTSM, and eTMF capabilities.
Why consider TrialKit? Its configuration flexibility and AI-assisted study development may help CROs reduce repetitive setup work while maintaining internal control over multiple studies.
Considerations: CROs should evaluate the learning curve for complex configurations, reporting capabilities, and AI usage costs.
Pricing: Subscription-based licensing; exact pricing available on request.
What Users Say About TrialKit
OpenClinica EDC
Best for: CROs prioritizing configurable EDC, transparent starting prices, and optional managed study-building services.
OpenClinica provides configurable clinical data capture with CDASH form libraries, data review, and reporting capabilities. It also offers AI-assisted, expert-managed study builds, giving CROs the option to supplement their internal study configuration resources.
Key capabilities
- Configurable eCRFs, CDASH form libraries, and edit checks.
- Query management, SDV, data review tables, and reporting.
- AI-assisted study-build services with human oversight.
- API access, EHR-to-EDC integrations, and connected eClinical modules.
Why consider OpenClinica? Its combination of configurable EDC, managed implementation services, and published pricing may appeal to CROs seeking flexibility in how studies are built and supported.
Considerations: The Launch plan has participant, site, and API restrictions. Its AI offering is more focused on assisted study building than AI-driven data review.
Pricing: Launch starts at $750/month; Core EDC with Reporting & Analytics starts at $3,000/month per study on a 12-month contract.
What Users Say About OpenClinica
What to Look for When Choosing EDC Software for Small and Mid-Sized CROs
The right EDC platform should fit your CRO’s operating model, not just meet a list of technical requirements. A system that works well for one study may become difficult to manage when multiple sponsors, amendments, and reporting deadlines overlap.
Use the following five areas to assess your options, then prioritize them according to your study portfolio, available resources, and sponsor requirements.
1. Control Over Study Configuration and Amendments
The important question is not simply whether an EDC is no-code or low-code, but how much work your team can complete independently.
Check whether data managers can modify eCRFs, visit schedules, and edit checks during an active study. Ask how changes are tested, approved, and introduced without affecting existing records or disrupting data collection.
Also establish which activities require vendor involvement. A system may support self-service form building while still requiring specialist support for complex amendments or integrations.
2. AI Capabilities That Support Actual Data Management Work
AI capabilities vary considerably between EDC Software providers. Some focus on generating study configurations, while others support medical coding, source data comparison, anomaly detection, or natural-language reporting.
CROs should evaluate AI based on the work it can support, not simply whether the vendor advertises AI features.
Consider whether the system can assist with identifying discrepancies, generating reports, or preparing queries, and how its outputs are verified. Human oversight, traceability, and role-based controls are particularly important when AI is used in regulated clinical workflows.
3. Multi-Sponsor Access and Integration Requirements
For CROs working with several sponsors, study-level permissions alone may not be sufficient.
Evaluate how the platform separates sponsor data, manages access across concurrent studies, and supports reusable configurations without exposing information between sponsors.
Integration requirements also deserve attention. Confirm whether EDC can exchange relevant data with RTSM, CTMS, ePRO, laboratories, and other systems used in the study. Determine which connections are native, API-based, or require custom development, and who maintains them when either system changes.
4. Regulatory Compliance, Validation, and Data Security
CROs should examine the evidence behind a vendor’s regulatory and security claims, rather than relying on a list of standards.
Request documentation supporting applicable requirements such as FDA 21 CFR Part 11, EU Annex 11, and ICH GCP, along with relevant privacy obligations. Review audit trails, electronic signatures, access controls, data retention, backup procedures, and available system validation packages.
ISO 27001 certifications and SOC 2 reports can provide additional security assurance, but they are not substitutes for validating an EDC system for its intended use.
For CROs serving multiple sponsors, accessible validation documentation and clearly defined vendor responsibilities can make sponsor qualification and inspection preparation more manageable.
5. Total Cost of Ownership Across Multiple Studies
The initial license fee rarely represents the complete operating cost of an EDC platform.
CROs should account for study builds, configuration changes, training, integrations, technical support, reporting, data exports, and any separately licensed AI capabilities.
Pay particular attention to the pricing structure. Per-study, per-user, per-subject, and portfolio-based agreements can produce different costs as the number of concurrent studies grows.
Ask vendors to provide costs for your expected study portfolio rather than relying on a single-study quote.
How to Choose the Right EDC Platform for Small and Mid-Sized CROs
Reducing study setup effort
Reusable libraries, independent configuration, AI-assisted study building, and validation workflows
Handling frequent protocol amendments
Reducing manual data management work
Once these priorities are established, narrow the options to two or three platforms and evaluate them against the same study requirements.
A practical approach is to provide each shortlisted vendor with a representative protocol, a typical amendment, and a reporting requirement. This makes it easier to compare the configuration effort, operational flexibility, and support needed under similar conditions.
Questions to Ask During an EDC Vendor Demo
Study setup
Can our data managers configure eCRFs and edit checks independently? What training is required?
A useful test: Ask each vendor to demonstrate the same mid-study amendment and explain every step from configuration through testing and release. This reveals differences in operational effort that may not appear in product brochures.
Choosing an EDC Platform That Can Grow With Your CRO
For small and mid-sized CROs, the best EDC platform is one that can support changing sponsor requirements without creating unnecessary configuration work, vendor dependency, or unpredictable costs.
The six platforms in this guide offer different approaches to these challenges. Some emphasize independent study configuration and controlled amendments, while others place greater focus on AI-assisted workflows, data integration, or implementation support. The right choice depends on which capabilities will make the greatest difference to your CRO’s daily operations and long-term costs.
Why Clinion EDC Is the Best Choice for Small and Mid-Sized CROs
— FAQ's
Frequently Asked Questions About EDC Software for CROs
The main difference is how the software is used. CROs typically manage clinical trials for multiple sponsors, requiring reusable study configurations, sponsor-specific access controls, and flexible licensing. Sponsors generally focus on managing and overseeing their own trials. Both require secure data capture, regulatory compliance, and reliable clinical data management.
Yes. Small CROs can build and manage studies without dedicated programmers using no-code or low-code EDC platforms. Trained data managers can configure eCRFs, edit checks, visit schedules, and routine protocol amendments. However, complex study logic, custom integrations, and validation activities may still require technical expertise.
Clinion EDC combines codeless study configuration, flexible protocol amendments, and AI-assisted clinical data management in one platform. CROs can build studies using reusable global libraries, manage mid-study changes without downtime, and use AI-assisted tools for data review, medical coding, and reporting. These capabilities help lean teams manage multiple sponsor studies with less routine programming dependency.
AI helps CROs automate repetitive clinical data management tasks, including study configuration, source data comparison, medical coding, discrepancy detection, and reporting. Some EDC platforms also support natural-language data queries and AI-assisted data review. These capabilities can reduce manual effort while keeping data validation and final decisions under human oversight.
Yes. A CRO can manage studies for multiple sponsors using a single EDC platform, provided it supports study-specific permissions, appropriate data separation, and concurrent study management. CROs should also verify whether the system offers centralized administration, reusable study templates, and cross-study reporting without exposing one sponsor's data to another.
EDC software pricing for small CROs varies by vendor, study size, licensing model, and required features. Some platforms offer published monthly starting prices, while others provide custom per-study or portfolio quotations. Total costs may include implementation, protocol amendments, integrations, AI modules, training, and ongoing support.
Clinion EDC differentiates itself through its combination of configurable data capture and AI-assisted clinical data management. While platforms such as Viedoc and Medrio emphasize flexible study configuration, Clinion also offers Agentic Assistant for natural-language data access and reporting, alongside AI-assisted source data review and medical coding. The right choice depends on each CRO's workflow, integration requirements, and budget.
Still have questions?
Explore how Clinion AI can accelerate your trial – reach out to our team.
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%